Pandemic influenza A/H1N1 virus infection and TNF, LTA, IL1B, IL6, IL8, and CCL

详细信息    查看全文

• 作者：Guadalupe Morales-García (1)
  Ramcés Falfán-Valencia (2)
  Román Alejandro García-Ramírez (1)
  ángel Camarena (2)
  Alejandra Ramirez-Venegas (2)
  Manuel Castillejos-López (2)
  Martha Pérez-Rodríguez (1)
  César González-Bonilla (3)
  Concepción Grajales-Mu?íz (3)
  Víctor Borja-Aburto (3)
  Juan Manuel Mejía-Aranguré (1)
  
• 关键词：TNF ; IL1B ; IL8 ; IL6 ; LTA ; CCL1 ; Influenza AH1N1
• 刊名：BMC Infectious Diseases
• 出版年：2012
• 出版时间：December 2012
• 年：2012
• 卷：12
• 期：1
• 全文大小：209KB
• 参考文献：1. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, Kumar A, Lim M, Shindo N, Penn C, Nicholson KG: Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. / N Engl J Med 2010, 362:1708-719. CrossRef
  2. Singanayagam A, Singanayagam A, Wood V, Chalmers JD: Factors associated with severe illness in pandemic 2009 influenza A (H1N1) infection: implications for triage in primary and secondary care. / J Infect 2011, 63:243-51. CrossRef
  3. Chowell G, Echeverría-Zuno S, Viboud C, Simonsen L, Tamerious J, Miller MA, Borja-Aburto VH: Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico. / PLoS Med 2011, 8:e1000436. CrossRef
  4. Ward KA, Spokes PJ, McAnulty JM: Case–control study of risk factors for hospitalization caused by pandemic (H1N1) 2009. / Emerg Infect Dis 2011, 17:1409-416.
  5. Fezeu L, Julia C, Henegar A, Bitu J, Hu FB, Grobbee DE, Kengne AP, Hercberg S, Czernichow S: Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. / Obes Rev 2011, 12:653-59. CrossRef
  6. Yu H, Feng Z, Uyeki TM, Liao Q, Zhou L, Feng L, Ye M, Xiang N, Huai Y, Yuan Y, Jiang H, Zheng Y, Gargiullo P, Peng Z, Feng Y, Zheng J, Xu C, Zhang Y, Shu Y, Gao Z, Yang W, Wang Y: Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. / Clin Infect Dis 2011, 52:457-65. CrossRef
  7. Reyes S, Montulla B, Martínez R, Córdoba J, Molina JM, Martí V, Martínez A, Ramírez P, Menéndez R: Risk factors of H1N1 etiology in pneumonia and impact on mortality. / Respir Med 2011, 105:1404-411. CrossRef
  8. Wen Y, Deng BC, Zhou Y, Wang Y, Cui W, Wang W, Liu P: Immunological features in patients with pneumonitis due to influenza A H1N1 infection. / J Investig Allergol Clin Immunol 2011, 21:44-0.
  9. To KK, Hung IF, Li IW, Lee KL, Koo CK, Yan WW, Liu R, Ho KY, Chu KH, Watt CL, Luk WK, Lai KY, Chow FL, Mok T, Buckley T, Chan JF, Wong SS, Zheng B, Chen H, Lau CC, Tse H, Cheng VC, Chan KH, Yuen KY: Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. / Clin Infect Dis 2010, 50:850-59. CrossRef
  10. Bermejo-Martin JF, de Lejarazu RO, Pumarola T, Rello J, Almansa R, Ramirez P, Martin-Loeches I, Varillas D, Gallegos MC, Serón C, Micheloud D, Gomez JM, Tenorio-Abreu A, Ramos MJ, Molina ML, Huidobro S, Sanchez E, Gordón M, Fernández V, Del Castillo A, Marcos MA, Villanueva B, López CJ, Rodríguez-Domínguez M, Galan JC, Cantón R, Lietor A, Rojo S, Eiros JM, Hinojosa C: Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. / Crit Care 2009, 13:R201. CrossRef
  11. Michaelis M, Doerr HW, Cinatl J Jr: Of chickens and men: avian influenza in humans. / Curr Mol Med 2009, 9:131-51. CrossRef
  12. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha DQ, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J: Fatal outcome of human influenza A (H5N1) is associated with high viral load of human influenza A. / Nat Med 2006, 12:1203-207. CrossRef
  13. Mainers TR, Szretter KJ, Perrone L, Belser JA, Bright RA, Zeng H, Tumpey TM, Katz JM: Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. / Immunol Rev 2008, 225:68-4. CrossRef
  14. Hagau N, Slavcovici A, Gonganau DN, Oltean S, Dirzu DS, Brezoszki ES, Maxim M, Ciuce C, Mlesnite M, Gavrus RL, Laslo C, Hagau R, Petrescu M, Studnicska DM: Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. / Crit Care 2010, 14:R203. CrossRef
  15. Wang B, Wang J, Zheng Y, Zhou S, Zhen J, Wang F, Ma X, Zeng Z, HBV Study Consortium: TNF-alpha-238 and ?08 polymorphisms with different outcomes of persistent hepatitis B virus infection in china. / Pathology 2010, 42:674-80. CrossRef
  16. Alssani B, Ogwaro KM, Shrestha S, Tang J, Breen EC, Wong HL, Jacobson LP, Rabkin CS, Ambinder RF, Martinez-Maza O, Kaslow RA: The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma. / J Acquir Immune Defic Syndr 2009, 52:170-79. CrossRef
  17. Gaudet MM, Egan KM, Lissowska J, Newcomb PA, Brinton LA, Titus-Ernstoff L, Yeager M, Chanock S, Welch R, Peplonska B, Trentham-Dietz A, Garcia-Closas M: Genetic variation in tumor factor and lymphotoxin-alpha (TNA-LTA) and breast cancer risk. / Human Genet 2007, 121:483-90. CrossRef
  18. Partida-Rodriguez O, Torres J, Flores-Luna L, Camorlinga M, Nieves-Ramirez M, Lazcano E, Perez-Rodriguez M: Polymorphism in TNF and HSP-70 show a significant association with gastric cancer and duodenal ulcer. / Int J Cancer 2010, 126:1861-868.
  19. Ned RM, Yesupriya A, Imperatore G, Smelser D, Moonesinghe R, Chang MH, Dowling NF: nflammation gene variants and susceptibility to albuminuria in U.S. population: analysis in the Third National Health and Nutrition Examination Survey (NHANES III), 1991-4. / BMC Med Genet 2010, 11:155. CrossRef
  20. Martinez-Carrillo DN, Garza-Gonzalez E, Betancout-Linares R, Mónico-Manzano T, Antúnez-Rivera C, Roman-Roman A, Flores-Alfaro E, Illades-Aguiar B, Fernández-Tilapa G: Association of ILB -511C/-31T haplotypes and Helicobacter Pylori VacA genotypes with gastric ulcer and chronic gastritis. / BMC Gastroenterol 2010, 10:126. CrossRef
  21. Vazarova B, Fernádez-Real JM, Knoweler WC, Gallart L, Hanson RL, Guber JD, Ricart W, Vendrell J, Richart C, Tataranni PA, Wolford JK: The interleukin-6 (?74) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. / Hum Genet 2003, 112:409-13.
  22. Qi L, Zhang C, van Dam RM, Hu FB: Interleukin-6 genetic variability and adiposity: association in two prospective cohorts and systematic review in 26,944 individuals. / J Clin Endocrinol Metab 2007, 92:3618-625. CrossRef
  23. Cheng CH, Lee YS, Tsau YK, Lin TY: Genetic polymorphisms and susceptibility to parenchymal renal infection among pediatric patients. / Pediatr Infect Dis J 2011, 30:309-14. CrossRef
  24. Heinzmann A, Ahlert I, Kurtz T, Berner R, Deichmann KA: Association study suggests opposite effects of polymorphism within IL8 on bronchial asthma and respiratory syncytial virus bronchiolitis. / J Allergy Clin Immunol 2004, 114:671-76. CrossRef
  25. Hacking D, Knight JC, Rockett K, Brown H, Frampton J, Kwiatkowski DP, Hull J, Udalova IA: Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility. / Genes Immun 2004, 5:274-82. CrossRef
  26. Hull J, Thomson A, Kwiatkowski D: Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. / Thorax 2000, 55:1023-027. CrossRef
  27. Takabatake N, Shibata Y, Abe S, Wada T, Machiva J, Igarashi A, Tokairin Y, Ji G, Sato H, Sata M, Takeishi Y, Emi M, Muramatsu M, Kubota I: A single nucleotide polymorphism in the CCL1 gene predicts acute exacerbations in chronic obstructive pulmonary disease. / Am J Respir Crit Care Med 2006, 174:875-85. CrossRef
  28. Camarena A, Juárez AM, Estrada A, Carrillo G, Falfán R, Zu?iga J, Navarro C, Granados J, Selman M: Major histocompatibility complex and tumor necrosis factor-α polymorphisms in pigeon breeder’s disease. / Am J Respir Crit Care Med 2001, 163:1528-533.
  29. Nieves ME, Partida O, Alegre P, Tapia MC, Pérez M: Characterization of single-nucleotide polymorphisms in the tumor necrosis factor α promoter region and lymphotoxin α in squamous intraepithelial lesion, precursors of cervical cancer. / Transl Oncol 2011, 4:336-44.
  30. Paskullin DD, Fallavena P, Paludo F, Borges T, Picanco J, Dias F, Alho C: TNF -308G > a promoter polymorphism (rs1800626) and outcome from critical illness. / Braz J Infec Dis 2011, 15:231-38. CrossRef
  31. Echevarría-Zuno S, Mejía-Aranguré JM, Mar-Obeso AJ, Grajales-Mu?iz C, Robles-Pérez E, González-León M, Ortega-Alvarez MC, Gonzalez-Bonilla C, Rascón-Pacheco RA, Borja-Aburto VH: Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. / Lancet 2009, 374:2072-079. CrossRef
  32. / WHO information for laboratory diagnosis of pandemic (H1N1) 2009 virus in humans–update. 2009. http://www.who.int/csr/resources/publications/swineflu/WHO_Diagnostic_RecommendationsH1N1_20090521.pdf (accessed May 26, 2009)
  33. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, Brammer TL, Cox NJ, Tumpey TM, Katz JM: Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. / N Engl J Med 2009, 361:1945-952. CrossRef
  34. Baguelin M, Hoschler K, Stanford E, Waight P, Hardelid P, Andrews N, Miller E: Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation. / PLoS One 2011, 6:e17074. CrossRef
  35. Papenburg J, Baz M, Hamelin Mè, Rhéaume C, Carbonneau J, Ouakki M, Rouleau I, Hardy I, Skowronski D, Roger M, Charest H, De Serres G, Boivin G: Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory-confirmed secondary attack rates and evidence of asymptomatic infections. / Clin Infect Dis 2010, 51:1033-041. CrossRef
  36. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/12/299/prepub
  
• 作者单位：Guadalupe Morales-García (1)
  Ramcés Falfán-Valencia (2)
  Román Alejandro García-Ramírez (1)
  ángel Camarena (2)
  Alejandra Ramirez-Venegas (2)
  Manuel Castillejos-López (2)
  Martha Pérez-Rodríguez (1)
  César González-Bonilla (3)
  Concepción Grajales-Mu?íz (3)
  Víctor Borja-Aburto (3)
  Juan Manuel Mejía-Aranguré (1)
  
  1. Coordinación de Investigación en Salud, Instituto Mexicano del Seguro Social (IMSS), Torre Academia Nacional de Medicina 4to piso, Av. Cuauhtémoc 330, 06720, México, DF, México
  2. Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Tlalpan 4502, 14080, México, DF, México
  3. Coordinación de Vigilancia Epidemiológica y Apoyo en Contingencias, IMSS, Mier y Pesado 120, 03100, México, DF, México
  

文摘

Background Some patients have a greater response to viral infection than do others having a similar level of viral replication. Hypercytokinemia is the principal immunopathological mechanism that contributes to a severer clinical course in cases of influenza A/H1N1. The benefit produced, or damage caused, by these cytokines in severe disease is not known. The genes that code for these molecules are polymorphic and certain alleles have been associated with susceptibility to various diseases. The objective of the present study was to determine whether there was an association between polymorphisms of TNF, LTA, IL1B, IL6, IL8, and CCL1 and the infection and severity of the illness caused by the pandemic A/H1N1 in Mexico in 2009. Methods Case–control study. The cases were patients confirmed with real time PCR with infection by the A/H1N1 pandemic virus. The controls were patients with infection like to influenza and non-familial healthy contacts of the patients with influenza. Medical history and outcome of the disease was registered. The DNA samples were genotyped for polymorphisms TNF rs361525, rs1800629, and rs1800750; LTA rs909253; IL1B rs16944; IL6 rs1818879; IL8 rs4073; and CCL1 rs2282691. Odds ratio (OR) and the 95% confidence interval (95% CI) were calculated. The logistic regression model was adjusted by age and severity of the illness in cases. Results Infection with the pandemic A/H1N1 virus was associated with the following genotypes: TNF rs361525 AA, OR = 27.00; 95% CI = 3.07-248.77); LTA rs909253 AG (OR = 4.33, 95% CI = 1.82-0.32); TNF rs1800750 AA (OR = 4.33, 95% CI = 1.48-2.64); additionally, LTA rs909253 AG showed a limited statistically significant association with mortality (p = 0.06, OR = 3.13). Carriers of the TNF rs1800629 GA genotype were associated with high levels of blood urea nitrogen (p = 0.05); those of the TNF rs1800750 AA genotype, with high levels of creatine phosphokinase (p=0.05). The IL1B rs16944 AA genotype was associated with an elevated number of leukocytes (p <0.001) and the IL8 rs4073 AA genotype, with a higher value for PaO2 mm Hg. Conclusion The polymorphisms of genes involved in the inflammatory process contributed to the severity of the clinical behavior of infection by the pandemic influenza A/H1N1 virus.